Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3142686rdf:typepubmed:Citationlld:pubmed
pubmed-article:3142686lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:3142686lifeskim:mentionsumls-concept:C0014792lld:lifeskim
pubmed-article:3142686lifeskim:mentionsumls-concept:C1179435lld:lifeskim
pubmed-article:3142686lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:3142686lifeskim:mentionsumls-concept:C0205148lld:lifeskim
pubmed-article:3142686lifeskim:mentionsumls-concept:C0377091lld:lifeskim
pubmed-article:3142686lifeskim:mentionsumls-concept:C1521827lld:lifeskim
pubmed-article:3142686lifeskim:mentionsumls-concept:C1705248lld:lifeskim
pubmed-article:3142686lifeskim:mentionsumls-concept:C1548799lld:lifeskim
pubmed-article:3142686lifeskim:mentionsumls-concept:C1524073lld:lifeskim
pubmed-article:3142686lifeskim:mentionsumls-concept:C0014162lld:lifeskim
pubmed-article:3142686lifeskim:mentionsumls-concept:C0449432lld:lifeskim
pubmed-article:3142686pubmed:dateCreated1989-1-10lld:pubmed
pubmed-article:3142686pubmed:abstractTextEndo-N-acetyl-beta-D-glucosaminidase F-Peptidyl N-glycosidase F preparations (abbreviated Endo F) and endo-beta-D-galactosidase were used to study the major human erythrocyte membrane glycoproteins and the components carrying the blood group A, B, Rhesus (D), and Duffy (Fya) antigens. The results are consistent with the known presence of an N-glycosyl-linked oligosaccharide on sialoglycoprotein alpha and the absence of such an oligosaccharide from sialoglycoprotein delta. Under the conditions used, only a portion of the N-glycosyl-linked oligosaccharides on band 3 molecules were cleaved by Endo F alone or by Endo F in combination with endo-beta-D-galactosidase. Immunoblotting experiments showed that treatment of red cells with Endo F alone had little effect on the components carrying blood group A and B antigen activity. However, Endo F used in combination with endo-beta-D-galactosidase caused a substantial reduction in the binding of monoclonal anti-A and anti-B antibodies. The results clearly show that sialoglycoproteins alpha and delta carry little or no blood group A or B activity. Endo F alone, or in combination with endo-beta-D-galactosidase, had no effect on the electrophoretic mobility of the Rh(D) polypeptide, supporting previous suggestions that this membrane polypeptide is unusual in not being glycosylated. Endo F had a dramatic effect on the electrophoretic mobility of the component(s) carrying blood group Fya activity. The diffuse Fya component of Mr 38,500-90,000 was sharpened to a band of Mr 26,000. Either endo-beta-D-galactosidase or neuraminidase treatment reduced the Mr of the Fya component(s) but did not significantly sharpen the bands, suggesting that the Fya component contains between 40-50% by mass of N-glycosyl-linked oligosaccharides.lld:pubmed
pubmed-article:3142686pubmed:languageenglld:pubmed
pubmed-article:3142686pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3142686pubmed:citationSubsetIMlld:pubmed
pubmed-article:3142686pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3142686pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3142686pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3142686pubmed:statusMEDLINElld:pubmed
pubmed-article:3142686pubmed:monthJullld:pubmed
pubmed-article:3142686pubmed:issn0008-6215lld:pubmed
pubmed-article:3142686pubmed:authorpubmed-author:MartinP GPGlld:pubmed
pubmed-article:3142686pubmed:authorpubmed-author:AnsteeD JDJlld:pubmed
pubmed-article:3142686pubmed:authorpubmed-author:TannerM JMJlld:pubmed
pubmed-article:3142686pubmed:authorpubmed-author:ParsonsS FSFlld:pubmed
pubmed-article:3142686pubmed:authorpubmed-author:MallinsonGGlld:pubmed
pubmed-article:3142686pubmed:authorpubmed-author:AventN DNDlld:pubmed
pubmed-article:3142686pubmed:authorpubmed-author:RidgwellKKlld:pubmed
pubmed-article:3142686pubmed:issnTypePrintlld:pubmed
pubmed-article:3142686pubmed:day15lld:pubmed
pubmed-article:3142686pubmed:volume178lld:pubmed
pubmed-article:3142686pubmed:ownerNLMlld:pubmed
pubmed-article:3142686pubmed:authorsCompleteYlld:pubmed
pubmed-article:3142686pubmed:pagination203-12lld:pubmed
pubmed-article:3142686pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3142686pubmed:meshHeadingpubmed-meshheading:3142686-...lld:pubmed
pubmed-article:3142686pubmed:meshHeadingpubmed-meshheading:3142686-...lld:pubmed
pubmed-article:3142686pubmed:meshHeadingpubmed-meshheading:3142686-...lld:pubmed
pubmed-article:3142686pubmed:meshHeadingpubmed-meshheading:3142686-...lld:pubmed
pubmed-article:3142686pubmed:meshHeadingpubmed-meshheading:3142686-...lld:pubmed
pubmed-article:3142686pubmed:meshHeadingpubmed-meshheading:3142686-...lld:pubmed
pubmed-article:3142686pubmed:meshHeadingpubmed-meshheading:3142686-...lld:pubmed
pubmed-article:3142686pubmed:year1988lld:pubmed
pubmed-article:3142686pubmed:articleTitleEffect of endoglycosidase F-peptidyl N-glycosidase F preparations on the surface components of the human erythrocyte.lld:pubmed
pubmed-article:3142686pubmed:affiliationDepartment of Biochemistry, University of Bristol, United Kingdom.lld:pubmed
pubmed-article:3142686pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3142686pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3142686lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3142686lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3142686lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3142686lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3142686lld:pubmed